Search research articles
Contact Us
Filters
Showing results (61-70 of 78) with videos related to
Page
of 8
Sort By:
RSC Advances
|
March 29, 2021
An efficient synthetic route to l-γ-methyleneglutamine and its amide derivatives, and their selective anticancer activity
Md Imran Hossain, Ajit G Thomas, Fakhri Mahdi, et al.
Pain Reports
|
June 21, 2018
Reduced intraepidermal nerve fibre density, glial activation, and sensory changes in HIV type-1 Tat-expressing female mice: involvement of Tat during early stages of HIV-associated painful sensory neuropathy
Rachel Wodarski, Deniz Bagdas, Jason J Paris, et al.
Current HIV Research
|
March 12, 2015
Opiate addiction therapies and HIV-1 Tat: interactive effects on glial [Ca²⁺]i, oxyradical and neuroinflammatory chemokine production and correlative neurotoxicity
Sylvia Fitting, Shiping Zou, Nazira El-Hage, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
May 6, 2017
Selective Vulnerability of Striatal D2 versus D1 Dopamine Receptor-Expressing Medium Spiny Neurons in HIV-1 Tat Transgenic Male Mice
Christina J Schier, William D Marks, Jason J Paris, et al.
Glycoconjugate Journal
|
December 1, 2022
Structural characterization and biological activity of an α-glucan from the mollusk Marcia hiantina (Lamarck, 1818)
Hoda Al Ahmed, Bernadeth F Ticar, Ian Black, et al.
Neuroscience Letters
|
August 26, 2022
Independent actions by HIV-1 Tat and morphine to increase recruitment of monocyte-derived macrophages into the brain in a region-specific manner
Crystal R Leibrand, Jason J Paris, Austin M Jones, et al.
Journal of Neurovirology
|
May 19, 2019
HIV-1 Tat and opioids act independently to limit antiretroviral brain concentrations and reduce blood-brain barrier integrity
Crystal R Leibrand, Jason J Paris, Austin M Jones, et al.
Research Square
|
February 24, 2023
Ionic Liquid Coating-Driven Nanoparticle Delivery to the Brain: Applications for NeuroHIV
Christine M Hamadani, Fakhri Mahdi, Anya Merrell, et al.
Experimental Neurology
|
September 12, 2022
Persistent sensory changes and sex differences in transgenic mice conditionally expressing HIV-1 Tat regulatory protein
Wisam Toma, Jason J Paris, Urszula O Warncke, et al.
Chemmedchem
|
January 19, 2022
6,5-Fused Ring, C2-Salvinorin Ester, Dual Kappa and Mu Opioid Receptor Agonists as Analgesics Devoid of Anxiogenic Effects
Nicholas S Akins, Nisha Mishra, Hannah M Harris, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 78) with videos related to
Sort By:
Page
of 8
RSC Advances
|
March 29, 2021
An efficient synthetic route to l-γ-methyleneglutamine and its amide derivatives, and their selective anticancer activity
Md Imran Hossain, Ajit G Thomas, Fakhri Mahdi, et al.
Pain Reports
|
June 21, 2018
Reduced intraepidermal nerve fibre density, glial activation, and sensory changes in HIV type-1 Tat-expressing female mice: involvement of Tat during early stages of HIV-associated painful sensory neuropathy
Rachel Wodarski, Deniz Bagdas, Jason J Paris, et al.
Current HIV Research
|
March 12, 2015
Opiate addiction therapies and HIV-1 Tat: interactive effects on glial [Ca²⁺]i, oxyradical and neuroinflammatory chemokine production and correlative neurotoxicity
Sylvia Fitting, Shiping Zou, Nazira El-Hage, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
May 6, 2017
Selective Vulnerability of Striatal D2 versus D1 Dopamine Receptor-Expressing Medium Spiny Neurons in HIV-1 Tat Transgenic Male Mice
Christina J Schier, William D Marks, Jason J Paris, et al.
Glycoconjugate Journal
|
December 1, 2022
Structural characterization and biological activity of an α-glucan from the mollusk Marcia hiantina (Lamarck, 1818)
Hoda Al Ahmed, Bernadeth F Ticar, Ian Black, et al.
Neuroscience Letters
|
August 26, 2022
Independent actions by HIV-1 Tat and morphine to increase recruitment of monocyte-derived macrophages into the brain in a region-specific manner
Crystal R Leibrand, Jason J Paris, Austin M Jones, et al.
Journal of Neurovirology
|
May 19, 2019
HIV-1 Tat and opioids act independently to limit antiretroviral brain concentrations and reduce blood-brain barrier integrity
Crystal R Leibrand, Jason J Paris, Austin M Jones, et al.
Research Square
|
February 24, 2023
Ionic Liquid Coating-Driven Nanoparticle Delivery to the Brain: Applications for NeuroHIV
Christine M Hamadani, Fakhri Mahdi, Anya Merrell, et al.
Experimental Neurology
|
September 12, 2022
Persistent sensory changes and sex differences in transgenic mice conditionally expressing HIV-1 Tat regulatory protein
Wisam Toma, Jason J Paris, Urszula O Warncke, et al.
Chemmedchem
|
January 19, 2022
6,5-Fused Ring, C2-Salvinorin Ester, Dual Kappa and Mu Opioid Receptor Agonists as Analgesics Devoid of Anxiogenic Effects
Nicholas S Akins, Nisha Mishra, Hannah M Harris, et al.
Page
of 8